162 related articles for article (PubMed ID: 15571503)
1. Therapy of systemic fungal infections.
Wu JJ; Pang KR; Huang DB; Tyring SK
Dermatol Ther; 2004; 17(6):532-8. PubMed ID: 15571503
[TBL] [Abstract][Full Text] [Related]
2. Antifungal agents and immunomodulators in systemic mycoses.
Khan ZK; Jain P
Indian J Chest Dis Allied Sci; 2000; 42(4):345-55. PubMed ID: 15597684
[TBL] [Abstract][Full Text] [Related]
3. Current and future therapy of invasive fungal infections.
Andriole VT
Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349
[TBL] [Abstract][Full Text] [Related]
4. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
5. Newer treatments for fungal infections.
Knapp KM; Flynn PM
J Support Oncol; 2005; 3(4):290-8. PubMed ID: 16092600
[TBL] [Abstract][Full Text] [Related]
6. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
Moudgal VV; Sobel JD
Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
[TBL] [Abstract][Full Text] [Related]
7. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for polyenes in treating invasive mycoses?
Cornely OA; Vehreschild JJ; Ullmann AJ
Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
[TBL] [Abstract][Full Text] [Related]
9. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
10. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach WJ; Reedy JL; Cramer RA; Perfect JR; Heitman J
Nat Rev Microbiol; 2007 Jun; 5(6):418-30. PubMed ID: 17505522
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
12. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Salavert M; Jarque I
Rev Esp Quimioter; 2006 Mar; 19(1):11-3. PubMed ID: 16688286
[No Abstract] [Full Text] [Related]
13. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
14. Emerging fungal resistance.
Baddley JW; Moser SA
Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
16. When primary antifungal therapy fails.
Nucci M; Perfect JR
Clin Infect Dis; 2008 May; 46(9):1426-33. PubMed ID: 18419447
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections and their treatment in the intensive care unit.
Sarosi GA
Curr Opin Crit Care; 2006 Oct; 12(5):464-9. PubMed ID: 16943727
[TBL] [Abstract][Full Text] [Related]
18. Increasing fungal infections in the intensive care unit.
De Pauw BE
Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
20. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]